Alcon abandons effort to purchase LENSAR after FTC scrutiny

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Dive Brief: Alcon and LENSAR agreed to call off their merger, Alcon said Monday. Alcon CEO David Endicott said the delay and costs associated with a Federal Trade Commission review made the transaction unattractive to pursue further.  In a Tuesday statement, the Federal Trade Commission said the merger would have combined the two most significant players in the mar ...